128 related articles for article (PubMed ID: 16209113)
1. [Trends in colorectal cancer vaccination].
Mocellin S; Campana LG
Recenti Prog Med; 2005; 96(7-8):338-43. PubMed ID: 16209113
[TBL] [Abstract][Full Text] [Related]
2. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials.
Mosolits S; Nilsson B; Mellstedt H
Expert Rev Vaccines; 2005 Jun; 4(3):329-50. PubMed ID: 16026248
[TBL] [Abstract][Full Text] [Related]
3. New strategies to improve the efficacy of colorectal cancer vaccines: from bench to bedside.
Mocellin S
Curr Opin Investig Drugs; 2006 Dec; 7(12):1052-61. PubMed ID: 17209522
[TBL] [Abstract][Full Text] [Related]
4. Priming anticancer active specific immunotherapy with dendritic cells.
Mocellin S
Curr Opin Investig Drugs; 2005 Jun; 6(6):576-81. PubMed ID: 15988908
[TBL] [Abstract][Full Text] [Related]
5. Part I: Vaccines for solid tumours.
Mocellin S; Mandruzzato S; Bronte V; Lise M; Nitti D
Lancet Oncol; 2004 Nov; 5(11):681-9. PubMed ID: 15522656
[TBL] [Abstract][Full Text] [Related]
6. Optimizing dendritic cell-based immunotherapy for cancer.
Zhong H; Shurin MR; Han B
Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
[TBL] [Abstract][Full Text] [Related]
7. Vaccination for treatment and prevention of cancer in animal models.
Cavallo F; Offringa R; van der Burg SH; Forni G; Melief CJ
Adv Immunol; 2006; 90():175-213. PubMed ID: 16730264
[TBL] [Abstract][Full Text] [Related]
8. Cancer immunotherapy, mathematical modeling and optimal control.
Castiglione F; Piccoli B
J Theor Biol; 2007 Aug; 247(4):723-32. PubMed ID: 17543345
[TBL] [Abstract][Full Text] [Related]
9. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies.
Atreya I; Neurath MF
Expert Rev Anticancer Ther; 2008 Apr; 8(4):561-72. PubMed ID: 18402523
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer vaccines in clinical trials.
Speetjens FM; Zeestraten EC; Kuppen PJ; Melief CJ; van der Burg SH
Expert Rev Vaccines; 2011 Jun; 10(6):899-921. PubMed ID: 21692708
[TBL] [Abstract][Full Text] [Related]
11. Active specific immunotherapy for colorectal cancer.
Indar AA; Maxwell-Armstrong CA
Expert Rev Anticancer Ther; 2003 Oct; 3(5):685-94. PubMed ID: 14599091
[TBL] [Abstract][Full Text] [Related]
12. Current immunotherapeutic strategies in colon cancer.
Morse M; Langer L; Starodub A; Hobeika A; Clay T; Lyerly HK
Surg Oncol Clin N Am; 2007 Oct; 16(4):873-900, x. PubMed ID: 18022550
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer vaccines: principles, results, and perspectives.
Mocellin S; Rossi CR; Lise M; Nitti D
Gastroenterology; 2004 Dec; 127(6):1821-37. PubMed ID: 15578520
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic cancer vaccines: an emerging treatment option.
King SE
Clin J Oncol Nurs; 2004 Jun; 8(3):271-8. PubMed ID: 15208821
[TBL] [Abstract][Full Text] [Related]
15. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
[TBL] [Abstract][Full Text] [Related]
16. A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
Posner MC; Niedzwiecki D; Venook AP; Hollis DR; Kindler HL; Martin EW; Schilsky RL; Goldberg RM; Mayer RJ
Ann Surg Oncol; 2008 Jan; 15(1):158-64. PubMed ID: 18008108
[TBL] [Abstract][Full Text] [Related]
17. Immunologic approaches to ovarian cancer treatment.
Sabbatini P; Odunsi K
J Clin Oncol; 2007 Jul; 25(20):2884-93. PubMed ID: 17617519
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial.
Harrop R; Connolly N; Redchenko I; Valle J; Saunders M; Ryan MG; Myers KA; Drury N; Kingsman SM; Hawkins RE; Carroll MW
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3416-24. PubMed ID: 16740766
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of active immunotherapy with PANVAC or autologous, cultured dendritic cells infected with PANVAC after complete resection of hepatic metastases of colorectal carcinoma.
Lou E; Marshall J; Aklilu M; Cole D; Chang D; Morse M
Clin Colorectal Cancer; 2006 Jan; 5(5):368-71. PubMed ID: 16512998
[No Abstract] [Full Text] [Related]
20. Cancer vaccines: a promising cancer therapy against all odds.
Silk AW; Finn OJ
Future Oncol; 2007 Jun; 3(3):299-306. PubMed ID: 17547525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
